GEVO
Gevo, Inc. Basic Materials Specialty Chemicals
9/12
Innovation Score
Red Flags (1)
SBC_HIGH (98% of revenue)
Patent Activity
2/3
6 patents found
OK_NORMALIZED
Cash Runway
3/3
Operating cash flow positive — self-funding.
Cash on hand: $67.6M
Cash on hand: $67.6M
Revenue Trajectory
3/3
Revenue: $217.8M
YoY Growth: +94.2%
YoY Growth: +94.2%
Management Quality
1/3
Insider ownership: 7.7%
SBC/Revenue: 98.4%
No reverse splits detected
SBC/Revenue: 98.4%
No reverse splits detected
Key Metrics
Market Cap
$452.7M
Revenue
$217.8M
Revenue Growth (YoY)
+94.2%
Cash on Hand
$67.6M
Cash Runway
Cash Flow Positive
Shares Outstanding
247.4M
Insider Ownership
7.7%
SBC / Revenue
98.4%
Sector / Industry
Basic Materials / Specialty Chemicals
Patents (6)
Match type: OK_NORMALIZED
- Selective formation of jet and diesel fuels from bio-based C3-C8 olefins via oligomerization with tungstated catalysts
- Simultaneous dehydration, dimerization, and metathesis of C2-C5 alcohols
- Upgrading of fusel oils over doped alumina
- Systems and processes for catalytic conversion of C1—C5 alcohols to C2—C5 olefin mixtures
- Bio-based olefin oligomerization via chabazite zeolite catalyst
7-Step Risk Assessment
How GEVO maps to our micro cap methodology:
- Innovation Signal 6 patents identified. This suggests the company is investing in defensible IP.
- Cash Runway Check Cash flow positive. No dilution risk from capital raises.
- Revenue Trajectory +94.2% YoY growth on $217.8M revenue. Strong growth trajectory.
- Management Alignment Insiders hold 7.7% of shares. SBC is 98.4% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $452.7M company.
Financial Detail
Free Cash Flow
$-17.1M
FCF Yield
-3.8%
Return on Equity
-45.6%
Debt / Equity
55.5%
Gross Margin
52.8%
Profit Margin
-83.7%
Operating Margin
-7.2%
Price / Book
1.47
Current Ratio
2.04
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-11-14